• 1
    Pignatti G, Barbanti-Bròdano G, Ferrari D, et al. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000; 375: 207213.
  • 2
    Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 1999; 86: 20452052.
  • 3
    Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC. Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984; 66: 13691374.
  • 4
    Park HC, Pyo HR, Shin KH, Suh CO. Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure. Oncology 2003; 64: 346352.
  • 5
    van der Hul RL, Seynaeve C, van Geel BN, Verweij J. Low dose methotrexate and vinblastine, given weekly to patients with desmoid tumours, is associated with major toxicity. Sarcoma 2003; 7: 153157.
  • 6
    Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 100: 612620.
  • 7
    Nakayama T, Tsuboyama T, Toguchida J, Hosaka T, Nakamura T. Natural course of desmoid-type fibromatosis. J Orthop Sci 2008; 13: 5155.
  • 8
    Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg 1999; 229: 866873.
  • 9
    Redmond OM, Stack JP, Dervan PA, Hurson BJ, Carney DN, Ennis JT. Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making. Radiology 1989; 172: 811815.
  • 10
    Rosenthal RE, Wozney P. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging. J Magn Reson Imaging 1991; 1: 547551.
  • 11
    Romero JA, Kim EE, Kim CG, Chung WK, Isiklar I. Different biologic features of desmoid tumors in adult and juvenile patients: MR demonstration. J Comput Assist Tomogr 1995; 19: 782787.
  • 12
    Casillas J, Sais GJ, Greve JL, Iparraguirre MC, Morillo G. Imaging of intra- and extraabdominal desmoid tumors. Radiographics 1991; 11: 959968.
  • 13
    Garant M, Remy H, Just N. Aggressive fibromatosis of the neck: MR findings. AJNR Am J Neuroradiol 1997; 18: 14291431.
  • 14
    Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E. Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol 2006; 186: 247254.
  • 15
    Hartman TE, Berquist TH, Fetsch JF. MR imaging of extraabdominal desmoids: differentiation from other neoplasms. AJR Am J Roentgenol 1992; 158: 581585.
  • 16
    Feld R, Burk DL Jr, McCue P, Mitchell DG, Lackman R, Rifkin MD. MRI of aggressive fibromatosis: frequent appearance of high signal intensity on T2-weighted images. Magn Reson Imaging 1990; 8: 583588.
  • 17
    Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401407.
  • 18
    Shen SH, Chiou YY, Wang JH, et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190: 481488.
  • 19
    Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008; 18: 486492.
  • 20
    Manenti G, Di Roma M, Mancino S, et al. Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3T. Radiol Med 2008; 113: 199213.
  • 21
    Barile A, Zugaro L, Catalucci A, et al. Soft tissue liposarcoma: histological subtypes, MRI and CT findings. Radiol Med. 2002; 104: 140149.
  • 22
    Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006; 239: 632649.
  • 23
    Oka K, Yakushiji T, Sato H, et al. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 2010; 39: 141146.
  • 24
    Murakami R, Hirai T, Sugahara T, et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology. 2009; 251: 838845.
  • 25
    Vandevenne JE, De Schepper AM, De Beuckeleer L, et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol 1997; 7: 10131019.
  • 26
    Shen SH, Chiou YY, Wang JH, et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008; 190: 481488.
  • 27
    Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172178.
  • 28
    National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage - the non-Hodgkin's lymphoma pathologic classification project. Cancer 1982; 49: 21122135.
  • 29
    Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skel Radiol 2000; 29: 555562.
  • 30
    Baur A, Huber A, Ertl-Wagner B, et al. Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR Am J Neuroradiol 2001 Feb; 22: 366372.